Pure seminoma in a male phenotype 46,XX true hermaphrodite

Journal of Urology

Volumn 164, Issue 1, 2000, Pages 125-126

  Malavaud, Bernard ^a   Mazerolles, Catherine ^a   Bieth, Eric ^a   Chevreau, Christine ^a   Le Frere, Marie Aude ^a   Alric, Laurent ^a  

^a CHU PURPAN   (France)

Author keywords

Hermaphroditism; Ovary; Phenotype; Seminoma; Testis

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HERMAPHRODITISM; HUMAN; KARYOTYPE 46,XX; MALE; PHENOTYPE; PRIORITY JOURNAL; SEMINOMA; TREATMENT OUTCOME;

EID: 0033938034     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67467-8     Document Type: Article

References (5)

1. Gourlay, W. A., Johnson, H. W., Pantzar, J. T. et al: Gonadal tumors in disorders of sexual differentiation. Urology, 43: 537, 1994
2. Krob, G., Braun, A. and Kuhnle, U.: True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr, 153: 2, 1994
3. Kolon, T. F., Ferrer, F. A. and McKenna, P. H.: Clinical and molecular analysis of XX sex reversed patients. J Urol, part 2, 160: 1169, 1998
4. Gauwitz, M. D. and Zagars, G. K.: Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol Biol Physiol, 24: 153, 1992
5. Culine, S., Theodore, C., Terrier-Lacombe, M. J. et al: Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial. J Urol, 157: 855, 1997